Kyamchurna

CHAPTER 1

RATIONALE

" To accept something as rational is to accept it as making sense, as appropriate, or required, or in accordance with some acknowledged goal, such as aiming at truth or aiming at the good."

Keeping the above things in mind provided me different ideas for my project which directed me toward supporting the topic with the proper logic. The rationale behind studying the topic "Exporting Kayamchurna to UAE" was to analyze the Indian and UAE market for Kayamchurna with contribution of Ayurvedic industry.

OBJECTIVE:

"First, have a definite, clear practical ideal; a goal, an objective. Second, have the necessary means to achieve your ends; wisdom, money, materials, and methods. Third, adjust all your means to that end."

The objective must be defined before any work is about to began because it sets the guidelines for working on that particular research providing researcher a wide criteria to accumulate an in depth knowledge on which one can work upon. Since I was working as secondary researcher I established following objectives for my topic.

* To identify the Indian and UAE market for Kayamchurna in present scenario

* To study the emerging trends in Indian Ayurvedic industry

* The purpose of this study is to carry out research for exploring opportunities for exporting ayurvedic laxatives of Sheth Brothers to UAE by studying political, economy, legal and cultural aspects.

METHODOLOGY

The study is description in nature data is collected from various journal, internet. The research project is basically a desk research work based on secondary data collected from various set of objectives. The source of data was mainly e-newspapers and journals, magazine, various internet sites.

CHAPTER 2

INDUSTRY OVERVIEW: INTRODUCTION

Ayurvedic medicines are produced by several thousand companies in India, but most of them are quite small, including numerous neighborhood pharmacies that compound ingredients to make their own remedies. It is estimated that the total value of products from the entire Ayurvedic production in India is on the order of one billion dollars (U.S.). The industry has been dominated by less than a dozen major companies for decades, joined recently by a few others that have followed their lead, so that there are today 30 companies doing a million dollars or more per year in business to meet the growing demand for Ayurvedic medicine. The products of these companies are included within the broad category of "fast moving consumer goods" (FMCG; which mainly involves foods, beverages, toiletries, cigarettes, etc.). Most of the larger Ayurvedic medicine suppliers provide materials other than Ayurvedic internal medicines, particularly in the areas of foods and toiletries (soap, toothpaste, shampoo, etc.), where there may be some overlap with Ayurveda, such as having traditional herbal ingredients in the composition of toiletries.

The key suppliers in Ayurveda are Dabur, Baidyanath, and Zandu, which together have about 85% of India's domestic market. These and a handful of other companies are mentioned repeatedly by various writers about the Ayurvedic business in India. Several small companies that have grown rapidly in recent years envision themselves as primary players in the Ayurvedic market. The market for Ayurvedic internal medicines is dominated by Chyawanprash, an herbal honey comprised of about 3 dozen ingredients, with amla (emblic myrobalans) as the key ingredient. The leader in this field is Dabur, which had a 69% market share at the end of 2002; followed by Baidyanath, with nearly 11%, and Zandu and Himani (Emami Group) with about 7.5% each. A variety of individual herbs, traditional formulations, and proprietary medicines make up the rest of the health products section involving internal remedies, while the remainder of the market is taken up by toothpastes and powders, skin creams, massage oils, shampoos, and other topical preparations. Two of the largest companies involved with providing traditional medicine products, such as the above, are Himalaya Drug Company and universal medicaments.

Exports of Ayurvedic medicines have reached a value of 100 million dollars a year (about 10% the value of the entire Ayurvedic industry in India). About 60% of this is crude herbs (to be manufactured into products outside India), about 30% is finished product shipped abroad for direct sales to consumers, and the remaining 10% is partially prepared products to be finished in the foreign countries.

STATUS OF AYURVEDA IN INDIA

The Indian government and non-government organizations have been collecting statistics on the Ayurvedic system in India and these data about the manpower and institutional aspects of Ayurveda have emerged:

* Number of registered medical practitioners: 366,812

* Number of dispensaries: 22,100

* Number of hospitals: 2,189

* Number of hospital beds: 33,145

* Number of teaching institutions (undergraduate): 187

* Number of upgraded postgraduate departments: 51

* Number of specialties in postgraduate medical training: 16

* Number of pharmacies manufacturing Ayurvedic medicines: 8,400

In India, 60% of registered physicians are involved in non-allopathic systems of medicine. In addition to the nearly 400,000 Ayurvedic practitioners, there are over 170,000 homeopathic physicians; India has about 500,000 medical doctors (similar to the number in the U.S., but serving nearly 4 times as many people). Reliance on Ayurvedic medicine is heavy in certain regions of India, such as Kerala in the Southwest. Many Ayurvedic practitioners in small villages are not registered.

MODERN MARKET DEVELOPMENTS

The SAARC (South Asia Association for Regional Cooperation) was formed in 1985; its member countries are India, Pakistan, Nepal, Bangladesh, Bhutan, Maldives, and Sri Lanka. These countries all have been influenced by Ayurvedic medicine. Trade in Ayurvedic medicines within the SAARC is mostly limited to raw materials that grow in one region (e.g., high mountains, northern climate) and are then exported to other regions (e.g., lowland southern areas).

Because